tiprankstipranks
Trending News
More News >
Cogent Biosciences (COGT)
NASDAQ:COGT
US Market

Cogent Biosciences (COGT) Cash flow

Compare
695 Followers

Cogent Biosciences Cash Flow

COGT's free cash flow for Q3 2025 was $-64.35M. For the 2025 fiscal year, COGT's free cash flow was decreased by $-51.94M and operating cash flow was $-64.29M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -207.79M$ -153.62M$ -118.64M$ -58.76M$ -35.85M
Investing Cash Flow
$ 38.28M$ -97.82M$ -124.72M$ -1.72M$ 8.42M
Financing Cash Flow
$ 214.45M$ 163.54M$ 163.56M$ 37.98M$ 232.20M
End Cash Position
$ 98.17M$ 53.23M$ 141.14M$ 220.94M$ 243.44M
Free Cash Flow
$ -208.36M$ -156.42M$ -125.50M$ -60.48M$ -35.85M
Currency in USD

Cogent Biosciences Cash Flow